Informação sobre produto
- 1-({(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-yl}carbonyl)-L-prolinamide
- 1-({5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-yl}carbonyl)prolinamide
- 2-Pyrrolidinecarboxamide, 1-[[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-hydroxy-1H-indol-2-yl]carbonyl]-, (2S)-
- 2-Pyrrolidinecarboxamide, 1-[[5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-hydroxy-1H-indol-2-yl]carbonyl]-, [2R-[2α(S*),3β]]-
- Indol-2-Ylcarbonyl)-L-Prolinamide
- Relcovaptan
- Sr 49049
- Sr 49059
SR 49059 is a vasopressin antagonist that was developed to treat prostate cancer. SR 49059 binds to the vasopressin receptor and blocks the binding of vasopressin, thereby preventing vasoconstriction and lowering blood pressure. SR 49059 has been shown to be a potent and selective antagonist at the V2 receptor in human prostate cancer cells. The drug also possesses biochemical properties that are similar to oxytocin, which may account for its low potency in humans. SR 49059 has not been studied extensively in women or in humans with congestive heart failure, but it appears to have a positive effect on diastolic pressure.
Propriedades químicas
Consulta técnica sobre: 3D-AGA37575 SR 49059
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
